Global Nutrigenomics Market - GLOBAL:2021

Market Report Coverage :
Start Year : 2021 - Forecast Year : 2031 - Start Value : $1,051.6 Million in 2021 - Forecast Value : $5,170.6 Million by 2031 - CAGR % : 0.17%
Description :
Market Report Coverage - NutrigenomicsMarket Segmentation• Application – Women’s Health, Digestive Health, Immune Health, and Others• Type – by Product (Probiotics and Prebiotics and Dietary Supplements) and by Service (Nutrigenomics Genetic Testing For Clinical Purpose and Nutrigenomics Genetic Testing For Research)Regional Segmentation• North America – U.S. and Canada• Europe – U.K., Germany, France, Italy, Spain• Asia-Pacific – Japan, China, India, Australia, and Rest-of-Asia-Pacific• Latin America – Brazil, Mexico, and Rest-of-Latin America• Rest-of-the-WorldMarket Growth Drivers• Rising Advancement in Genomics Technology• Increasing Incidence of Lifestyle-Related Diseases• Increasing Demand for Preventive Medication Through Personalized Nutrition• Limited Efficacy Rate of DrugsMarket Challenges• Insufficient Application-Based Research Hindering Market Pull• Lack of Awareness Regarding the Usage of Probiotics and Prebiotics• Non-Harmonized Government Regulations on Probiotics and Prebiotics Focusing on NutrigenomicsMarket Opportunities• Massive Scope for Phenomenal Profits Through Venturous Investments• Integrative Industry-Academia Collaboration• Rise of Next-Generation Probiotics• Shifting of Reimbursement Policies Toward Enhanced Genetics CoverageKey Companies ProfiledBioGaia, DuPont de Nemours, Inc., Nutrigenomix Inc., MedGenome, Garden of Life, LLC, Ingredion Incorporated, Jarrow Formulas Inc., geneOmbio, GX Sciences, Inc., DNAfit, Yakult Honsha Co., Ltd., Koninklijke DSM N.V., XCODE LifeKey Questions Answered in this Report:• What are the most common genetic conditions that have a significant role of nutrition metabolism?• What emerging trends are being followed by the companies in the global nutrigenomics market?• How are the key market players performing research investments in the respective market?• What are the major strategies opted by the key players for advancing in the global nutrigenomics market?• What are the regulations pertaining to the global nutrigenomics market among different regions and their impact on respective markets?• What are the initiatives implemented by different government bodies regulating the development and commercialization of nutrigenomic tests and associated platforms?• How has COVID-19 impacted the global nutrigenomics market?• How will the urgency of the pandemic influence the global nutrigenomics market?• Which are the leading companies dominating the global nutrigenomics market?• What is the reimbursement scenario of the tests offered in the global nutrigenomics market?• Based on the application type, which global nutrigenomics market application is anticipated to witness a massive rise in demand during the forecast period 2021-2031?• How is each segment of the global nutrigenomics market expected to grow during the forecast period, and what revenue is expected to be generated by each of the segments by the end of 2031?• How is the global nutrigenomics industry anticipated to evolve during the forecast period 2021-2031?• What are the leading trends and consumer preferences witnessed in the global nutrigenomics market?Market OverviewThe concept of nutrigenomics has emerged with an idea to assist an individual in achieving a lasting dietary behavior change that is beneficial for health. Nutrigenomics aims to elucidate the impact of diet on human health. The bioactive food compounds can interact with genes affecting the transcription factors, protein expression, and metabolite production. The study of these complex interactions requires the development of advanced analytical approaches combined with bioinformatics. The advancements in omics technology have opened gateways to deliver the biomarkers for health and comfort, disclose early indicators for a disease disposition, assist in differentiating dietary responders from non-responders, and, last but not least, discover bioactive, beneficial food components.Further, the increasing rate of obesity and lifestyle-related diseases has led to the rise in the focus on diet-related changes in metabolism and gene. Additionally, the evolution of technology has increased the pace of the market advancements in nutrigenomics.The segments included in the comprehensive market study are:• by Application• by Type o by Product o by Service• by Region The global nutrigenomics market, based on type, is further segmented into product (dietary usage) and by service (nutrigenomic genetic testing). The dietary usage products involve probiotics and prebiotics offered by the company that are impacting the genome directly or indirectly. Further, the genetic testing services in nutrigenomics involved offers insights regarding the diet that has an impact on gene.Competitive LandscapeThe global nutrigenomics market consists of numerous large- and small-scale manufacturers and service providers. Presently, with the increasing rate of molecular advancements and the rise in the adoption of genetic tests, there has been an expansion of opportunities for the nutrigenomics market. Some of the strategies opted by the key players within the market are new product offerings, product approvals, partnerships and alliances, mergers and acquisitions, and business expansions.In the five years (January 2017- June 2021), the market witnessed 23 product offerings, 25 synergistic activities, six funding and investments, and five business expansions. The increasing awareness for genetic testing and nutrigenomic diet such as prebiotic and probiotic food has majorly attributed to the growing prominence for nutrigenomics.On the basis of region, North America holds the largest share of the nutrigenomics market owing to improved health consciousness, better genetic testing facilities, and favorable regulatory policies in the region. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period.
Countries Covered :
North America U.S. CanadaEurope Germany Italy France Spain U.K.Asia-Pacific China Japan India Australia Rest-of-Asia-PacificLatin America Brazil Mexico Rest-of-Latin-AmericaRest-of-the-World
Keywords :
Nutrigenomics Market, Nutrigenomics Industry, Nutrigenomics Report, Nutrigenomics Market Forecasts, Nutrigenomics Market Trends, Nutrigenomics Market Companies, Nutrigenomics Market Analysis, Nutrigenomics Industry Analysis, What is Nutrigenomics, Nutrigenomics Definition, Nutrigenomics Market Competitive Landscape, Nutrigenomics Market Drivers, Nutrigenomics Market Segments, Nutrigenomics Market Outlook, Nutrigenomics Market Opportunity, Nutrigenomics Market Growth, Nutrigenomics Market Share, Nutrigenomics Market Size, Nutrigenomics Market by Application, Nutrigenomics Market by Type, Nutrigenomics Market by Region, Nutrigenomics Market by Product, Nutrigenomics Market by Service, Women’s Health Nutrigenomics Market, Digestive Health Nutrigenomics Market, Immune Health Nutrigenomics Market, Probiotics Nutrigenomics Market, Prebiotics Nutrigenomics Market, Dietary Supplement Nutrigenomics Market, Prebiotics and Dietary Supplement Nutrigenomics Market, Nutrigenomics Genetic Testing For Clinical Purpose, Nutrigenomics Genetic Testing For Research, North America Nutrigenomics Market, Europe Nutrigenomics Market, Asia-Pacific Nutrigenomics Market, Latin America Nutrigenomics Market, Mexico Nutrigenomics Market
Press Release :
The global nutrigenomics market is projected to reach $5,170.6 million by 2031, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 17.26% during the forecast period 2021-2031.The comprehensive study of the global nutrigenomics market by BIS Research extensively covers the following:• Market numbers on micro-segments that are influencing the market• More than 100 products present in the market• Market share analysis for more than ten key players• Detailed global and regional market share analysis, including the scrutiny of more than 15 countries • Study of data of more than 15 companiesBIS Research study indicates that insufficient application-based research in nutrigenomics, low awareness and acceptance for nutrigenomic testing, rising advancements of genomic technology are fueling the growth of the market.The study highlights the various emerging opportunities, such as the rise of next-generation probiotics, increasing industry and academia collaboration, and the scope of profit through venturous investments that can be leveraged by players operating in the market.The market intelligence by BIS Research additionally throws a spotlight on the key industry restraints that have an influence on the industry going forward.To gain a holistic view of the market, data from different segments of the market has been analyzed minutely. These segments include applications, by type, and region. The type segment has been further bifurcated into service (nutrigenomic genetic testing) and product (dietary usage). The product analysis of the global market includes data analysis on the satisfaction level. The study is majorly centered on the regional and country-level segments.To emphasize the dominance of the preimplantation segment over the carrier screening segment under the application category of the nutrigenomics market in 2020 and 2031, Nitish Kumar Singh, Principal Analyst – BIS Research, states, "The nutrigenomics market has undergone a transition post-COVID-19 due to the increase in the research studies depicting the role of probiotics and prebiotics in modulating our immune responses as an ultimate effect of the genome-diet interaction under the concept of extended nutrigenomics. Hence, the demand for such products has also increased with the increasing consciousness regarding health.”Key insights have been drawn from in-depth interviews with the key opinion leaders of more than 20 leading companies, market participants, and vendors. The key players profiled in the report include BioGaia AB, DowDuPont Inc, Ingredion Incorporated, Yakult Honsha Co., Ltd., Koninklijke DSM N.V., Probi AB, Gardens of Life, LLC, MedGenome, Nutrigenomix, Jarrow Formulas Inc., geneOmbio, GX Sciences, DNAfit, and XCODE Life.The study also offers strategic recommendations that can help organizations in tracking various products, trends, and technologies that are changing the dynamics of the market. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives.Who should buy this report?• Manufacturers of probiotics and prebiotics• Manufacturers of dietary supplements • Companies offering genetic testing services• Companies offering kits to perform genetic testing How can the market intelligence on nutrigenomics market add value to an organization’s decision-making process?• Aids in product development • Helps in targeting a segment for launching a new product • Offers go-to-market strategies for the different source type• Supports in diversifying the product portfolio basis risk and progression of technology• Assists in exploring newer applications• Supports in analyzing the competitors’ strategic developmentsInsightful Questions Covered to Enable Companies take Strategic Decisions• What are the most common genetic conditions that have a significant role of nutrition metabolism?• What emerging trends are being followed by the companies in the global nutrigenomics market?• How are the key market players performing research investments in the respective market?• What are the major strategies opted by the key players for advancing in the global nutrigenomics market?• What are the regulations pertaining to the global nutrigenomics market among different regions and their impact on respective markets?• What are the initiatives implemented by different government bodies regulating the development and commercialization of nutrigenomic tests and associated platforms?• How has COVID-19 impacted the global nutrigenomics market?• How will the urgency of the pandemic influence the global nutrigenomics market?• Which are the leading companies dominating the global nutrigenomics market?• What is the reimbursement scenario of the tests offered in the global nutrigenomics market?• Based on the application type, which global nutrigenomics market application is anticipated to witness a massive rise in demand during the forecast period 2021-2031?• How is each segment of the global nutrigenomics market expected to grow during the forecast period, and what revenue is expected to be generated by each of the segments by the end of 2031?• How is the global nutrigenomics industry anticipated to evolve during the forecast period 2021-2031?• What are the leading trends and consumer preferences witnessed in the global nutrigenomics market?
Companies Mentioned :
BioGaiaDuPont de Nemours, Inc.Nutrigenomix Inc.MedGenomeGarden of Life, LLCIngredion IncorporatedJarrow Formulas Inc.geneOmbioGX Sciences, Inc.DNAfitYakult Honsha Co., Ltd.Koninklijke DSM N.V.XCODE Life
Press Release :
The global nutrigenomics market is projected to reach $5,170.6 million by 2031, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 17.26% during the forecast period 2021-2031.The comprehensive study of the global nutrigenomics market by BIS Research extensively covers the following:• Market numbers on micro-segments that are influencing the market• More than 100 products present in the market• Market share analysis for more than ten key players• Detailed global and regional market share analysis, including the scrutiny of more than 15 countries • Study of data of more than 15 companiesBIS Research study indicates that insufficient application-based research in nutrigenomics, low awareness and acceptance for nutrigenomic testing, rising advancements of genomic technology are fueling the growth of the market.The study highlights the various emerging opportunities, such as the rise of next-generation probiotics, increasing industry and academia collaboration, and the scope of profit through venturous investments that can be leveraged by players operating in the market.The market intelligence by BIS Research additionally throws a spotlight on the key industry restraints that have an influence on the industry going forward.To gain a holistic view of the market, data from different segments of the market has been analyzed minutely. These segments include applications, by type, and region. The type segment has been further bifurcated into service (nutrigenomic genetic testing) and product (dietary usage). The product analysis of the global market includes data analysis on the satisfaction level. The study is majorly centered on the regional and country-level segments.To emphasize the dominance of the preimplantation segment over the carrier screening segment under the application category of the nutrigenomics market in 2020 and 2031, Nitish Kumar Singh, Principal Analyst – BIS Research, states, "The nutrigenomics market has undergone a transition post-COVID-19 due to the increase in the research studies depicting the role of probiotics and prebiotics in modulating our immune responses as an ultimate effect of the genome-diet interaction under the concept of extended nutrigenomics. Hence, the demand for such products has also increased with the increasing consciousness regarding health.”Key insights have been drawn from in-depth interviews with the key opinion leaders of more than 20 leading companies, market participants, and vendors. The key players profiled in the report include BioGaia AB, DowDuPont Inc, Ingredion Incorporated, Yakult Honsha Co., Ltd., Koninklijke DSM N.V., Probi AB, Gardens of Life, LLC, MedGenome, Nutrigenomix, Jarrow Formulas Inc., geneOmbio, GX Sciences, DNAfit, and XCODE Life.The study also offers strategic recommendations that can help organizations in tracking various products, trends, and technologies that are changing the dynamics of the market. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives.Who should buy this report?• Manufacturers of probiotics and prebiotics• Manufacturers of dietary supplements • Companies offering genetic testing services• Companies offering kits to perform genetic testing How can the market intelligence on nutrigenomics market add value to an organization’s decision-making process?• Aids in product development • Helps in targeting a segment for launching a new product • Offers go-to-market strategies for the different source type• Supports in diversifying the product portfolio basis risk and progression of technology• Assists in exploring newer applications• Supports in analyzing the competitors’ strategic developmentsInsightful Questions Covered to Enable Companies take Strategic Decisions• What are the most common genetic conditions that have a significant role of nutrition metabolism?• What emerging trends are being followed by the companies in the global nutrigenomics market?• How are the key market players performing research investments in the respective market?• What are the major strategies opted by the key players for advancing in the global nutrigenomics market?• What are the regulations pertaining to the global nutrigenomics market among different regions and their impact on respective markets?• What are the initiatives implemented by different government bodies regulating the development and commercialization of nutrigenomic tests and associated platforms?• How has COVID-19 impacted the global nutrigenomics market?• How will the urgency of the pandemic influence the global nutrigenomics market?• Which are the leading companies dominating the global nutrigenomics market?• What is the reimbursement scenario of the tests offered in the global nutrigenomics market?• Based on the application type, which global nutrigenomics market application is anticipated to witness a massive rise in demand during the forecast period 2021-2031?• How is each segment of the global nutrigenomics market expected to grow during the forecast period, and what revenue is expected to be generated by each of the segments by the end of 2031?• How is the global nutrigenomics industry anticipated to evolve during the forecast period 2021-2031?• What are the leading trends and consumer preferences witnessed in the global nutrigenomics market?
Headline :
Global Nutrigenomics Market to Reach $5,170.6 Million by 2031
Table of Contents :
1 Nutrigenomics: Product Definition1.1 Inclusion:1.2 Exclusion:1.2.1 Key Questions Answered by the Research Study2 Research Methodology2.1 Primary Data Sources2.2 Secondary Data Sources2.3 Market Estimation Model2.4 Assumptions and Limitations3 Global Nutrigenomics Market: An Overview3.1 Evolution of Nutrigenomics as Personalized Food3.2 Nutrigenetics and Nutrigenomics: Focusing on Gene and Diet Interaction3.3 Scenario of Genetic Testing in Nutrigenomics3.4 Impact of COVID-19 on Global Nutrigenomics Market3.5 COVID-19 Affecting Supply Chain of Nutrigenomics Market3.6 Interruption in Research and Clinical Development and Commercial Operation3.6.1 Research and Clinical Development3.6.2 Commercial Operation and Access3.7 Navigating Crisis Recovery and Looking to the Future4 Global Nutrigenomics Market: Industry Analysis4.1 Legal and Regulatory Framework4.1.1 Legal Requirements and Framework in the U.S.4.1.2 Legal Requirements and Framework in Europe4.1.3 Legal Requirements and Framework in Asia-Pacific4.1.3.1 Japan4.1.3.2 China4.2 Patent Landscape5 Global Nutrigenomics Market: Market Dynamics5.1 Market Drivers5.1.1 Rising Advancement in Genomics Technology5.1.2 Increasing Incidence of Lifestyle-Related Diseases5.1.3 Increasing Demand for Preventive Medication Through Personalized Nutrition5.1.4 Limited Efficacy Rate of Drugs5.2 Market Restraints5.2.1 Insufficient Application-Based Research Hindering Market Pull5.2.2 Lack of Awareness Regarding the Usage of Probiotics and Prebiotics5.2.3 Non-Harmonized Government Regulations on Probiotics and Prebiotics Focusing on Nutrigenomics5.3 Market Opportunities5.3.1 Massive Scope for Phenomenal Profits Through Venturous Investments5.3.2 Integrative Industry-Academia Collaboration5.3.3 Rise of Next-Generation Probiotics5.4 Shifting of Reimbursement Policies Toward Enhanced Genetics Coverage6 Global Nutrigenomics Market: Competitive Landscape6.1 Key Developments and Strategies6.2 New Offerings6.3 Partnerships and Alliances6.4 Funding & Investment and Business Expansion6.5 Merger and Acquisition6.6 Other Strategies6.7 Market Share Analysis6.8 Growth-Share Analysis7 Global Nutrigenomics Market, by Application7.1 Overview7.2 Women’s Health7.3 Digestive Health7.4 Immune Health7.5 Others8 Global Nutrigenomics Market, by Type8.1 Global Nutrigenomics Market, by Product8.1.1 Probiotics8.1.2 Prebiotics and Dietary Supplement8.2 Global Nutrigenomics Market, by Service8.2.1 Nutrigenomics Genetic Testing (For Clinical Purpose)8.2.2 Nutrigenomics Genetic Testing (For Research)9 Global Nutrigenomics Market, by Region9.1 Overview9.2 North America9.2.1 U.S.9.2.2 Canada9.3 Europe9.3.1 Germany9.3.2 Italy9.3.3 France9.3.4 U.K.9.3.5 Spain9.4 Asia-Pacific9.4.1 China9.4.2 Japan9.4.3 India9.4.4 Australia9.4.5 Rest-of-Asia-Pacific9.5 Latin America9.5.1 Brazil9.6 Mexico9.7 Rest-of-Latin America9.8 Rest-of-the-World10 Company Profiles10.1 Overview10.2 BioGaia10.2.1 Company Overview10.2.2 Role of Bioagia in the Global Nutrigenomics Market10.2.3 Financials10.2.4 SWOT Analysis10.3 DuPont de Nemours, Inc.10.3.1 Company Overview10.3.2 Role of DuPont de Nemours, Inc. in the Global Nutrigenomics Market10.3.3 Financials10.3.4 SWOT Analysis10.4 Nutrigenomix Inc.10.4.1 Company Overview10.4.2 Role of Nutrigenomix Inc. in the Global Nutrigenomics Market10.4.3 SWOT Analysis10.5 MedGenome10.5.1 Company Overview10.5.2 Role of MedGenome in the Global Nutrigenomics Market10.5.3 SWOT Analysis10.6 Garden of Life, LLC10.6.1 Company Overview10.6.2 Role of Garden of Life, LLC in the Global Nutrigenomics Market10.6.3 SWOT Analysis10.7 Ingredion Incorporated10.7.1 Company Overview10.7.2 Role of Ingredion Incorporated in the Global Nutrigenomics Market10.7.3 Financials10.7.4 SWOT Analysis10.8 Jarrow Formulas Inc.10.8.1 Company Overview10.8.2 Role of Jarrow Formulas Inc. in the Global Nutrigenomics Market10.8.3 SWOT Analysis10.9 geneOmbio10.9.1 Company Overview10.9.2 Role of geneOmbio in the Global Nutrigenomics Market10.9.3 SWOT Analysis10.1 GX Sciences, Inc.10.10.1 Company Overview10.10.2 Role of GX Sciences, Inc.in the Global Nutrigenomics Market10.10.3 SWOT Analysis10.11 DNAfit10.11.1 Company Overview10.11.2 Role of DNAfit in the Global Nutrigenomics Market10.11.3 SWOT Analysis10.12 Yakult Honsha Co., Ltd.10.12.1 Company Overview10.12.2 Role of Yakult Honsha Co., Ltd. in the Global Nutrigenomics Market10.12.3 Financials10.12.4 SWOT Analysis10.13 Koninklijke DSM N.V.10.13.1 Company Overview10.13.2 Role of Koninklijke DSM N.V. in the Global Nutrigenomics Market10.13.3 Financials10.13.4 SWOT Analysis10.14 XCODE Life10.14.1 Company Overview10.14.2 Role of XCODE Life in the Global Nutrigenomics Market10.14.3 SWOT AnalysisList of Tables Table 3.1: Impact of SNP and Nutrition HealthTable 7.1: Documented Microbial Associations with Disease StatusList of Figures Figure 1: Prevalence of Obesity in the U.S.Figure 2: Global Nutrigenomics Market, 2020-2031Figure 3: Impact AnalysisFigure 4: Global Nutrigenomics Market Growth-Share Analysis (by Company), 2020Figure 1.1: Concept of Extended NutrigenomicsFigure 1.2: Global Nutrigenomics Market SegmentationFigure 2.1: Global Nutrigenomics Market Research MethodologyFigure 2.2: Primary Research MethodologyFigure 2.3: Bottom-up ApproachFigure 3.1: Global Nutrigenomics Market, 2020-2031Figure 3.2: Global Nutrigenomics Market, by Product (Dietary Usage), 2020-2031Figure 3.3: Global Nutrigenomics Market, by Service (Nutrigenomic Genetic Testing), 2020-2031Figure 3.4: Anatomy of Gene Diet InteractionFigure 3.5: Positive and Negative Impact of COVID-19 on Global Nutrigenomics MarketFigure 3.6: Pre-COVID-19 and Post-COVID-19 Scenario of Global Nutrigenomics MarketFigure 3.7: Measure to Navigate Crisis RecoveryFigure 4.1: Guidelines for the Evaluation of Probiotics for Food UseFigure 4.2: Number of Patents (by Year), 2017-2020Figure 5.1: Impact AnalysisFigure 5.2: Diet and Disease LinkageFigure 5.3: Deaths Owing to Non-Communicable Disorders, 2015-2019Figure 6.1: Share of Key Developments and Strategies, January 2018-June 2021Figure 6.2: Product Offering Share (by Company), January 2018-June 2021Figure 6.3: Partnerships and Alliances Activities Share (by Company), January 2018- June 2021Figure 6.4: Funding & Investment and Business Expansion (by Company), January 2018-June 2021Figure 6.5: Mergers and Acquisitions (by Company), January 2018-June 2021Figure 6.6: Other Activities (by Company), January 2018-June 2021Figure 6.7: Global Nutrigenomics Market Share Analysis, by Dietary Usage 2020Figure 6.8: Global Nutrigenomics Market Share Analysis , by Nutrigenomic Testing Market, 2020Figure 6.9: Global Nutrigenomics Market Growth-Share Analysis (by Company), 2020Figure 7.1: Share of Global Nutrigenomics Market (by Application), $Million, 2020-2031Figure 7.2: Inter-Related Factors Governing Women’s HealthFigure 7.3: Global Nutrigenomics Market, by Women’s Health, 2020-2031Figure 7.4: Global Nutrigenomics Market, by Digestive Health, 2020-2031Figure 7.5: Global Nutrigenomics Market, by Immune Health, 2020-2031Figure 7.6: Global Nutrigenomics Market, by Other Applications, 2020-2031Figure 8.1: Global Nutrigenomics Market, by Product, 2020-2031Figure 8.2: Global Nutrigenomics Market, by Probiotics, 2020-2031Figure 8.3: Global Nutrigenomics Market, by Prebiotics and Dietary Supplement, 2020-2031Figure 8.4: Effect of genes on different aspects of healthFigure 8.5: Global Nutrigenomics Market, by Nutrigenomic Genetic Testing (For Clinical Purpose), 2020-2031Figure 8.6: Global Nutrigenomics Market, by Nutrigenomic Genetic Testing (For Research Purpose), 2020-2031Figure 9.1: North America Nutrigenomics Market, 2020-2031Figure 9.2: North America: Market DynamicsFigure 9.3: North America Nutrigenomics Market (by Country), 2020-2031Figure 9.4: U.S. Nutrigenomics Market, 2020-2031Figure 9.5: Canada Nutrigenomics Market, 2020-2031Figure 9.6: Europe Nutrigenomics Market, 2020-2031Figure 9.7: Europe: Market DynamicsFigure 9.8: Europe Nutrigenomics Market (by Country), 2020-2031Figure 9.9: Germany Nutrigenomics Market, 2021-2031Figure 9.10: Italy Nutrigenomics Market, 2020-2031Figure 9.11: France Nutrigenomics Market, 2020-2031Figure 9.12: U.K. Nutrigenomics Market, 2020-2031Figure 9.13: Spain Nutrigenomics Market, 2020-2031Figure 9.14: Asia-Pacific Nutrigenomics Market, 2020-2031Figure 9.15: Asia-Pacific: Market DynamicsFigure 9.16: Asia-Pacific Nutrigenomics Market (by Country), 2020-2031Figure 9.17: China Nutrigenomics Market, 2021-2031Figure 9.18: Japan Nutrigenomics Market, 2020-2031Figure 9.19: India Nutrigenomics Market, 2021-2031Figure 9.20: Australia Nutrigenomics Market, 2020-2031Figure 9.21: Rest-of-Asia-Pacific Nutrigenomics Market, 2020-2031Figure 9.22: Latin America Nutrigenomics Market, 2020-2031Figure 9.23: Latin America: Market DynamicsFigure 9.24: Latin America Nutrigenomics Market (by Country), 2020 and 2031Figure 9.25: Brazil Nutrigenomics Market, 2020-2031Figure 9.26: Mexico Nutrigenomics Market, 2020-2031Figure 9.27: Rest-of-Latin America Nutrigenomics Market, 2020-2031Figure 9.28: Rest-of-the-World Nutrigenomics Market, 2020-2031Figure 10.1: Shares of Key Company ProfilesFigure 10.2: BioGaia: Overall Product OfferingsFigure 10.3: BioGaia: Overall Financials, 2018-2020Figure 10.4: BioGaia: Revenue (by Region), 2018-2020Figure 10.5: BioGaia: R&D Expenditure, 2018-2020Figure 10.6: BioGaia: SWOT AnalysisFigure 10.7: DuPont de Nemours, Inc.: Overall Product OfferingsFigure 10.8: DuPont de Nemours, Inc.: Overall Financials, 2018-2020Figure 10.9: DuPont de Nemours, Inc.: Revenue (by Region), 2018-2020Figure 10.10: DuPont de Nemours, Inc.: R&D Expenditure, 2018-2020Figure 10.11: DuPont de Nemours, Inc.: SWOT AnalysisFigure 10.12: Nutrigenomix Inc.: Overall Product OfferingsFigure 10.13: Nutrigenomix Inc.: SWOT AnalysisFigure 10.14: MedGenome: Overall Product PortfolioFigure 10.15: MedGenome: SWOT AnalysisFigure 10.16: Garden of Life, LLC: Overall Product PortfolioFigure 10.17: Garden of Life, LLC: SWOT AnalysisFigure 10.18: Ingredion Incorporated: Overall Product OfferingsFigure 10.19: Ingredion Incorporated: Overall Financials, 2018-2020Figure 10.20: Ingredion Incorporated: Revenue (by Segment), 2018-2020Figure 10.21: Ingredion Incorporated: Revenue (by Region), 2018-2020Figure 10.22: Ingredion Incorporated: R&D Expenditure, 2018-2020Figure 10.23: Ingredion Incorporated: SWOT AnalysisFigure 10.24: Jarrow Formulas Inc.: Overall Product PortfolioFigure 10.25: Jarrow Formulas Inc.: SWOT AnalysisFigure 10.26: geneOmbio: Product Portfolio for Nutrigenomics MarketFigure 10.27: geneOmbio.: SWOT AnalysisFigure 10.28: GX Sciences, Inc.: Overall Product OfferingsFigure 10.29: GX Sciences, Inc.: SWOT AnalysisFigure 10.30: DNAfit: Overall Product OfferingsFigure 10.31: DNAfit: SWOT AnalysisFigure 10.32: Yakult Honsha Co., Ltd.: Overall Product OfferingsFigure 10.33: Yakult Honsha Co., Ltd: Overall Financials, 2017-2019Figure 10.34: Yakult Honsha Co., Ltd: Revenue (by Segment), 2017-2019Figure 10.35: Yakult Honsha Co., Ltd.: SWOT AnalysisFigure 10.36: Koninklijke DSM N.V.: Overall Product OfferingsFigure 10.37: Koninklijke DSM N.V.: Overall Financials, 2018-2020Figure 10.38: Koninklijke DSM N.V.: Revenue (by Segment), 2018-2020Figure 10.39: Koninklijke DSM N.V.: Revenue (by Region), 2018-2020Figure 10.40: Koninklijke DSM N.V.: R&D Expenditure, 2018-2020Figure 10.41: Koninklijke DSM N.V.: SWOT AnalysisFigure 10.42: XCODE Life: Overall Product PortfolioFigure 10.43: XCODE Life: SWOT Analysis